IP Library Granted Patent US 10,064,426
Granted Patent B2
US 10,064,426 · App. 15/230,865 · Granted Sep 4, 2018

Probiotics for use in expecting female mammals for enhancing the immunity of their offspring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,064,426
App. No.
15/230,865
Granted
Sep 4, 2018
Kind
B2
Abstract

The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of an offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of their offspring against infectious diseases.

Claims (20)

1. A method for improving immunity in an offspring, the method comprising:

administering to an expecting female mammal daily for all of the gestation period a composition comprising an effective amount of Lactobacillus rhamnosus CGMCC 1.3724 so as to boost the immunity of the offspring after birth.

2. The method of claim 1 wherein the administering of the composition to the female mammal induces boosting the innate immune functions and promoting specific immune response to infectious antigens of the offspring.

3. The method of claim 1 wherein the composition reinforces the transmission of immune competences from the female to the offspring.

4. The method of claim 1 wherein the female mammal is human.

5. The method of claim 1 wherein the composition is administered orally to the female.

6. The method of claim 1 wherein the composition is administered to the female mammal for part of the lactation period of the offspring.

7. The method of claim 1 wherein the composition comprises ingredients selected from the group consisting of inulin, fructooligosaccharide (FOS), short-chain fructooligosaccharide (short chain FOS), galacto-oligosaccharide (GOS), xylooligosaccharide (XOS), glanglioside, partially hydrolysed guar gum, acacia gum, soybean-gum, Lactowolfberry, wolfberry extracts and mixtures thereof.

8. The method of claim 1 wherein the immunity boost comprises an increase in the ability of the offspring to respond to an antigenic exposure.

9. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of the specific antibodies to the antigens in the serum, saliva or feces of the offspring.

10. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of the total poly-reactive antibodies in the offspring.

11. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of cellular immune response in the blood of the offspring.

12. The method of claim 8 wherein the antigenic exposure comprises exposure to at least one agent selected from the group consisting of viruses, bacteria, infective parasites infection and mixtures thereof.

13. The method of claim 8 wherein the increased ability to respond to the antigenic exposure contributes to better protect the offspring against infections in early life.

14. The method of claim 1 wherein the immunity boost reaches its maximum during the lactation period, or during juvenile phase of the offspring.

15. The method of claim 1 wherein the composition is further administered to the offspring during a period selected from the group consisting of lactation, after a full weaning and after a partial weaning.

16. The method of claim 1 wherein the composition is administered in a form selected from the group consisting of food, drinks, dietary supplements and pharmaceutical compositions.

17. The method of claim 1 wherein the immunity boost reaches its maximum between birth (day 0) and day 180 of life.

18. A method for boosting the immunity of an offspring, the method comprising:

administering to an expecting female mammal daily for all of the gestation period a composition comprising Lactobacillus rhamnosus CGMCC 1.3724 in an amount equivalent to between 10 3 and 10 10 cfu per gram of dry composition so as to boost the immunity of the offspring after birth.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2016
From: BENYACOUB, JALIL; BLUM-SPERISEN, STEPHANIE; ROCHAT, FLORENCE; VON DER WEID, THIERRY
To: NESTEC S.A.
Reel/Frame 039405/0447 →